Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Baker McKenzie advises on the sale of Vitabiotics to Bain Capital

Дата публикации: 27-07-2026 00:00:00



Основное содержимое страницы с новостью.

Leading global law firm, Baker McKenzie, is advising Professor Ajit Lalvani on the sale of Vitabiotics to Bain Capital.

Vitabiotics was founded in 1971 by Professor Kartar Lalvani OBE, and has grown from a pioneering British family business into one of the world’s most recognised independent, science-led nutraceutical companies. Its portfolio comprises a number of trusted brands, including Pregnacare, Perfectil, Wellman, Wellwoman, Osteocare and the Ultra range. The company exports to over 70 countries worldwide, and the transaction comprises the UK operations, together with the wider Vitabiotics group, including Meyer Organics in India and certain operations in Africa.

Completion of the transaction remains subject to customary regulatory approvals and closing conditions.

The Baker McKenzie deal team was led by London Head of M&A, David Scott, working closely with Senior Associate, Ryan Howlett and Associate, Nikki Bradford.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Baker McKenzie Advises on Memo Therapeutics' Sale to Ipsen and Related Carve-Out018.3301-07-2026
2Baker McKenzie Advises Bain Capital Life Sciences on Investment in Swixx BioPharma01005-06-2026
3Baker McKenzie Advises Bayer on USD 2.45 billion Acquisition of Perfuse Therapeutics018.3306-05-2026
4Baker McKenzie Advises Merit Medical on the Acquisition of View Point Medical08.407-04-2026
5Baker McKenzie Advises Chemomab on Merger with Scipher Medicine01010-07-2026
6Baker McKenzie Advises Sino Biopharm on up to US$1.53 Billion Exclusive License Agreement with Sanofi for Rovadicitinib015.8812-03-2026
7Baker McKenzie Advises Servier on the Acquisition of Day One Biopharmaceuticals for Approximately USD 2.5 Billion016.2510-03-2026
8Baker McKenzie Advises a Consortium led by SPE Capital, and included EBRD, Proparco and BIO on their Investment in Leading Ophthalmic Pharmaceutical Manufacturer09.1501-04-2026
9Baker McKenzie Advises Joint Bookrunners on Sunway Healthcare’s MYR 3.28 Billion IPO018.3318-03-2026
10Baker McKenzie has advised STADA on the acquisition of rights to Locobase® from Karo Healthcare01005-05-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10. Источник: www.bakermckenzie.com.